|
Welcome to this edition |
30 April 2007 |
We're well into 2007 already and I hope that it is shaping up as an exciting and successful year for you. 2006 was a great year for Northbank – we grew 40% in client revenues and added new team members to match this growth, who bring additional skills and experience (see People). For our clients 2006 was also an exciting year – we worked with clients to announce over €500 million in additional finance, with several clients also achieving significant deals and transactions. Northbank's communications programmes can help build long-term value for clients by combining creativity, market knowledge, strategic thinking and effective execution. If we can help you in any way we look forward to hearing from you. Have a good year!
Sue Charles, CEO |
|
Relocation, Relocation
On the 9th February, Northbank relocated its London operations to its newly refurbished offices at 85 Tottenham Court Road. The move reflects Northbank's growth over recent years and the expansion of its London-based team. If you're nearby, feel free to call in.
View details |
|
Brand New Novozymes Delta
Over a period of a year, Northbank rebranded and repositioned Delta Biotechnology and then integrated its new brand into the established global Novozymes brand following Delta's acquisition.
View case study |
|
PowderMed Sold to Pfizer
In Q4 2006, Pfizer acquired Northbank client, PowderMed, a venture-
backed immunotherapeutic company based in Oxford, UK. Northbank had supported PowderMed since its inception in 2004 in all aspects of its communications including corporate image, web site and media relations.
View news item |
|
Launch of Forbion Capital Partners
In January 2007, Northbank helped launch Forbion Capital Partners, formerly ABN AMRO Capital Life Sciences, as a new wholly independent
life sciences venture capital group. Northbank worked with the Forbion team to develop messaging and execute the media lauch.
View case study |
|
|
Top News |
Events We Are Supporting |
 |
The new website developed for Oxitec formed a critical component of its positioning as a world-leader in biological insect pest control. More... |
 |
Northbank supported UK-listed biotech company, Oxford BioMedica by promoting its lead product, TroVax, as it started Phase III development. More... |
 |
When Sigma-Aldrich's senior executives wanted to hone their media relations skills, they asked Northbank's CEO, Sue Charles, to run media training workshops over two days at their St Louis headquarters. More... |
 |
Over the last year alone, Northbank has successfully delivered communications programmes that have helped our life sciences clients raise over €250 million in private equity financings, over €550 million in partnering deals and facilitated two major acquisitions by blue chip pharma companies. More... |
|
Biotech and Finance Forum
Stuttgart, Germany
18 Jun 2007
Bioversity London 2007
London, UK
20 Jun 2007
9th International Conference on Biology and Synchrotron Radiation
Manchester, UK
13-17 Aug 2007
Biotech in Europe Investors Forum
Zurich, Switzerland
2-3 Oct 2007
4th Annual Asia Pacific Life Science Forum
London, UK
9-10 Oct 2007
 Genesis VII
London, UK
13 Dec 2007
|
|
In Brief |
Northbank provided marketing communications and PR support for Biacore during the SBS 12th annual Conference and Exhibition in Seattle, Washington in September 2006. More...
Solexa, now merged with Illumina, Inc. a leading developer and marketer of next-generation tools for the analysis of genetic variation and function, has worked with Northbank since 2002. During this time Northbank has helped to create brand identity and marketing materials, in addition to providing global conference and media relations support.
More...
MAT Biopharma, a French biotech company needed a freshened up website which communicated the company’s capabilities in the development of antibody-based therapeutics. Northbank created a new design that clearly conveys key messages and provides the company with a distinctive look through monochrome photography. More...
New brand, messaging and creative theme was created by Northbank for the Micro and Nano Technology (MNT) Network. More...
In preparing for a funding round, Upfront needed strategic repositioning. Northbank accomplished this through a rewrite of Upfront’s business plan and investor presentation. More...
Northbank boosted Nitec’s profile with a brand new website and a high impact press release publicizing positive Phase III results for their lead product Lodotra™. More... |
|
Meet Us At |
|
Date |
Event |
Location |
Attending |
|
21-22 May 2007 |
Bio€quity Europe 2007 |
Glasgow, UK |
Sue Charles, Adam Michael |
|
7 Jun 2007 |
BioDundee International Conference |
Dundee, UK |
Sue Charles |
|
18 Jun 2007 |
BioFinance Europe |
London, UK |
Sue Charles, Tristan Jervis |
|
18 Jun 2007 |
Biotech and Finance Forum |
Stuttgart, Germany |
Douglas Pretsell |
|
20 Jun 2007 |
Bioversity London 2007 |
London, UK |
Lorna Watson |
|
21 Jun 2007 |
EPIC: European Partnering & Investment Conference |
London, UK |
Sue Charles |
|
26-28 Jun 2007 |
Euro-Biotech Forum 2007 |
Paris, France |
Katja Stout |
|
27-29 Jun 2007 |
ERBI's 9th Annual Biopartnering Exchange Event |
Cambridge, UK |
Lorna Watson |
|
26-28 Sep 2007 |
EuroBiO 2007 |
Lille, France |
Katja Stout |
|
|
New Biz |
People |
In recent months, Northbank has started working with a number of new clients including:
AM-Pharma
Amsterdam Molecular Technologies
Biota
Clinuvel
Forbion Capital Partners
Fusion Antibodies
GATC Biotech
Hamamatsu Photonics
InferMed
Lab21
London Genetics
Mesoblast
PanGenetics
PepTcell
PerkinElmer
Pronota
Protagen
For our full client list, click here |
In line with Northbank’s growth, our team has expanded over recent months:
The London office also saw three internal promotions. Katja Stout, co-founder of the agency in 2002 has been voted onto the board of directors and becomes Director from Associate Director. Sarah Jeffery and Lorna Watson both of whom joined in 2005, move up from Senior Account Manager to Account Director. |
|
   |
Email: info[at]northbankcommunications.com
www.northbankcommunications.com
 |
London Tel:
+44 (0)20 7268 3002
Congleton Tel:
+44 (0)1260 296 500
Munich Tel:
+49 (0)89 5700 1806 |
|
|
